Summit Therapeutics Share Discussion Threads

[moneymunch] 17/9/2024 17:29

Wow wow wow, alas sold out a long time ago, but all the very best to all those who held a few. Gl :-)

[sasannach] 13/9/2024 15:57

Typical I have been top slicing thinking this is way over valued and it just cant stop!! Up 2200% on what is left.

£15B Market cap is ridiculous. Glad to see it rising but how can it be valued so high? Does anyone have a view (realistic!!) on the potential revenue or buy out?

[football] 13/9/2024 15:29

one maybe right



cautiousmoney26 Jul '24 - 16:19 - 25828 of 25834


hhhmmmmmm


$100 dollar per share ???

[football] 09/9/2024 15:28

well done any long time holders here today

(63.33%)

[timbo003] 09/9/2024 12:34

I only hold a few (as certificates purchased whilst on AIM). Received a letter from the Delaware unclaimed property offices about a month ago about my holding, so filled out the necessary forms to claim them and submitted it with the prerequisite ID, my only two options were to either have them transfered to a US broker account (I have no idea how would I get one of those when I am a UK citizen based in the UK and I dont want one anyway) or for the unclaimed property office to sell them and credit my bank account.

They have now provided me with a claim number but they seem to be taking their time to complete the task as I get this message every time I log on:

"Our office is reviewing the documentation provided for completeness, accuracy and to validate your identify or rightful ownership of the property. We are unable to provide an exact timeframe to review the documents as each circumstance is different"

[euroto] 09/9/2024 12:28

About time !. I've been here years !

[1gw] 09/9/2024 12:14

Amazing. Isn't biotech wonderful when it works? I guess they must have had a major pivot from antibiotics to oncology? I should have kept a few...

[waterloo01] 09/9/2024 12:03

Stunning news. Shame I don't hold any

[timbo003] 09/9/2024 11:19

I suspect we are going to have a blue day here today 🙂

[cautiousmoney] 26/7/2024 15:19

$ 11.38

well, the 7000 adr's well and truly out of the bottom drawer now

:-))

good job i filled the yankee tax form in !

might be time to cash in














or








wait for the big takeover ??




hhhmmmmmm


$100 dollar per share ???

[cautiousmoney] 29/6/2024 14:51

Looks like the old dog is laive and kicking at least Duggan now a billionaire , lets hope the trials come good !

[algernon2] 02/5/2023 21:10

Hi folks, a blast from the past.

[chrisatrdg] 09/1/2023 22:18

Maybe Summit -SMMT on the NASDAQ may be worth another look see JP Morgan presentation today.

[1gw] 06/12/2022 21:44

Life in the old dog yet? No longer invested here, but noticed this headline on the Endpoints summary. Duggan seems to like SMMT as a vehicle.

"Bouncing from major setback, Summit hands out $500M cash for cancer drug — thanks to a loan from billionaire CEO"

[chrisatrdg] 04/10/2022 17:51

Thanks waterloo01 - I also saw the update & glad I bailed out last year but then added into H&W which is currently not looking good.Regards Chris

PS Hope all is well with you.

[waterloo01] 04/10/2022 13:33

Summit Therapeutics (NASDAQ:SMMT), a biotech focused on infectious diseases, dropped ~5% pre-market Tuesday after the company announced it would discontinue a pediatric clinical trial for lead asset ridinilazole for Clostridioides difficile infection.
The decision follows a Type C meeting the company conducted with the FDA in which the regulator cited the need for at least one additional registrational trial to allow a potential marketing authorization for ridinilazole.
After that, the company has decided to divest ridinilazole or seek partners to advance its studies further, SMMT said in a regulatory filing on Tuesday.
In December, the company said that its Phase 3 Ri-CoDIFy study for ridinilazole failed to meet the main goal in patients with C. difficile infection.

[clintdavid1] 19/8/2022 12:22

Up 478%-increases his stake by huge amount=arrogance?

[waterloo01] 28/7/2022 19:39

Well well the Thetons are fallible, who'd have thought it. LOL trying to raise $100m (ie 'get me outa here' Duggan.) The arrogance. Hello to all old SUMers! Glyn had a very close shave

[clarkey26] 11/1/2022 09:06

Not sure back to purely early stage, I believe they will intend to progress c-diff, ultimately the trial showed a superior SCR, just not a big enough gap to be considered statistically significant. So something which might be equally as good with SCR but with ststisticly superior reduced reoccurrence rate. They noted in the presentation this should have been a primary end point for the trial but it was designed pre their involvement.
Guess it will be down to regulatory view and cost of drug and commercialisation. Might be worth a toe back in water.
Otherwise yes seemed a lot of good talk in the presentation but nothing concrete to support it and on that front, yes very early stage!

[waterloo01] 11/1/2022 07:24

Personally I'd avoid. Back to early stage development and way too early to consider investing IMO

[chrisatrdg] 10/1/2022 21:28

Did anyone listen to todays presentation:

Summit Therapeutics Inc. (NASDAQ: SMMT) reminds interested stakeholders that it will today present the Company’s vision and its intended future development pathways at the 40th Annual J.P. Morgan Healthcare Conference at approximately 3:45 PM EST.

Robert W. Duggan, Chairman and Chief Executive Officer, and Dr. Maky Zanganeh, Chief Operating Officer and a member of Summit’s Board of Directors, will provide details regarding Summit’s current plans with respect to its future research and clinical development goals. A live version of the presentation will be accessible on the home page of our website: hxxps://lnkd.in/dA2iEQAs. An archived edition of the session will be available later in the day.

Edit: They clearly think there is value to be obtained going forward all very enthusiastic maybe worth a punt at these low prices.

[chrisatrdg] 22/12/2021 08:23

Hi waterloo01 - I also Sold out back in September & made a modest profit.I was very wary of Duggan's decision to combine the study but from my understanding of the guy that was par for the course.

As for the future a lot depends on the 'Discuva' platform which is a big ask.

We can only wait for the publication of the C-Diff data & go from there.

Happy Christmas to all.

PS Fingers crossed for my Harland & Wolff shares.